These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

838 related articles for article (PubMed ID: 11585923)

  • 41. Solution structure of the receptor tyrosine kinase EphB2 SAM domain and identification of two distinct homotypic interaction sites.
    Smalla M; Schmieder P; Kelly M; Ter Laak A; Krause G; Ball L; Wahl M; Bork P; Oschkinat H
    Protein Sci; 1999 Oct; 8(10):1954-61. PubMed ID: 10548040
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action.
    Jalink K; Eichholtz T; Postma FR; van Corven EJ; Moolenaar WH
    Cell Growth Differ; 1993 Apr; 4(4):247-55. PubMed ID: 7684247
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interaction of MAP kinase with MAP kinase kinase: its possible role in the control of nucleocytoplasmic transport of MAP kinase.
    Fukuda M; Gotoh Y; Nishida E
    EMBO J; 1997 Apr; 16(8):1901-8. PubMed ID: 9155016
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone.
    Conover JC; Doetsch F; Garcia-Verdugo JM; Gale NW; Yancopoulos GD; Alvarez-Buylla A
    Nat Neurosci; 2000 Nov; 3(11):1091-7. PubMed ID: 11036265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Negative regulation of RPE cell attachment by carbohydrate-dependent cell surface binding of galectin-3 and inhibition of the ERK-MAPK pathway.
    Alge-Priglinger CS; André S; Schoeffl H; Kampik A; Strauss RW; Kernt M; Gabius HJ; Priglinger SG
    Biochimie; 2011 Mar; 93(3):477-88. PubMed ID: 21094672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Kos1, a nonreceptor tyrosine kinase that suppresses Ras signaling.
    Hoare K; Hoare S; Smith OM; Kalmaz G; Small D; Stratford May W
    Oncogene; 2003 Jun; 22(23):3562-77. PubMed ID: 12789265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
    Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential role of beta(1C) and beta(1A) integrin cytoplasmic variants in modulating focal adhesion kinase, protein kinase B/AKT, and Ras/Mitogen-activated protein kinase pathways.
    Fornaro M; Steger CA; Bennett AM; Wu JJ; Languino LR
    Mol Biol Cell; 2000 Jul; 11(7):2235-49. PubMed ID: 10888665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative analysis of embryonic gene expression defines potential interaction sites for Xenopus EphB4 receptors with ephrin-B ligands.
    Helbling PM; Saulnier DM; Robinson V; Christiansen JH; Wilkinson DG; Brändli AW
    Dev Dyn; 1999 Dec; 216(4-5):361-73. PubMed ID: 10633856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma.
    Tang XX; Brodeur GM; Campling BG; Ikegaki N
    Clin Cancer Res; 1999 Feb; 5(2):455-60. PubMed ID: 10037197
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling.
    Dikic I; Blaukat A
    Cell Biochem Biophys; 1999; 30(3):369-87. PubMed ID: 10403057
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The c-Abl tyrosine kinase contributes to the transient activation of MAP kinase in cells plated on fibronectin.
    Renshaw MW; Lewis JM; Schwartz MA
    Oncogene; 2000 Jun; 19(28):3216-9. PubMed ID: 10918577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras.
    Cacalano NA; Sanden D; Johnston JA
    Nat Cell Biol; 2001 May; 3(5):460-5. PubMed ID: 11331873
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of Rap1 activity is involved in ephrinB1-induced cell contraction.
    Riedl JA; Brandt DT; Batlle E; Price LS; Clevers H; Bos JL
    Biochem J; 2005 Jul; 389(Pt 2):465-9. PubMed ID: 15725075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of fibronectin matrix assembly by activated Ras in transformed cells.
    Brenner KA; Corbett SA; Schwarzbauer JE
    Oncogene; 2000 Jun; 19(28):3156-63. PubMed ID: 10918570
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Crystal structure of the ligand-binding domain of the receptor tyrosine kinase EphB2.
    Himanen JP; Henkemeyer M; Nikolov DB
    Nature; 1998 Dec; 396(6710):486-91. PubMed ID: 9853759
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Eph receptors and ephrins.
    Jensen PL
    Stem Cells; 2000; 18(1):63-4. PubMed ID: 10661574
    [No Abstract]   [Full Text] [Related]  

  • 58. Calcium and calmodulin are essential for Ras-GRF1-mediated activation of the Ras pathway by lysophosphatidic acid.
    Zippel R; Balestrini M; Lomazzi M; Sturani E
    Exp Cell Res; 2000 Aug; 258(2):403-8. PubMed ID: 10896791
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of EPH receptor tyrosine kinase CEK5 and its ligand Cek5-L/ELF-2/LERK2/hElk-L in the development of the chick retina.
    Sefton M; Nieto A
    Int J Dev Biol; 1996; Suppl 1():143S-144S. PubMed ID: 9087734
    [No Abstract]   [Full Text] [Related]  

  • 60. Raf kinase inhibitor protein enhances neuronal differentiation in human SH-SY5Y cells.
    Hellmann J; Rommelspacher H; Mühlbauer E; Wernicke C
    Dev Neurosci; 2010 Mar; 32(1):33-46. PubMed ID: 19955695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.